| ¿µ¹® | symptomatic therapy | ÇÑ±Û | ´ëÁõ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | º´ÀÇ ¿øÀÎÀ» ã¾Æ ¾ø¾Ö±â °ï¶õÇÑ »óȲ¿¡¼, °ÑÀ¸·Î ³ªÅ¸³ º´ÀÇ Áõ»ó¿¡ ´ëÀÀÇÏ¿© óġ¸¦ ÇÏ´Â Ä¡·á¹ý. ¿ÀÌ ³ôÀ» ¶§¿¡ ¾óÀ½ÁָӴϸ¦ ´ë°Å³ª ÇØ¿Á¦¸¦ ½á¼ ¿À» ³»¸®°Ô ÇÏ´Â µûÀ§°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±¿ä¹ý |
|---|---|---|---|
| ¼³¸í | X¼±, ¥ã¼±ÀÇ ÀüÀÚ¹æ»ç¼±À̳ª ÀüÀÚ¼±, ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÇ ÀÔÀÚ¹æ»ç¼±À» ÀÌ¿ëÇØ, ÁÖ·Î ¾Ç¼º Á¾¾ç Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â Ä¡·á¹ýÀÌ´Ù. ¾Ï¼¼Æ÷°¡ ÁÖÀ§ÀÇ Á¤»ó¼¼Æ÷º¸´Ùµµ ¹æ»ç¼± °¨¼ö¼ºÀÌ ³ôÀº Á¡À» ÀÌ¿ëÇÏ¿©, Á¤»ó¼¼Æ÷ÀÇ ¼Õ»óÀ» °¡´ÉÇÑ ÇÑ ÃÖ¼Ò·Î ¾ïÁ¦ÇÏ¸é¼ ¾Ï¼¼Æ÷¸¦ ÆÄ±«ÇÑ´Ù. »ç¿ëµÇ´Â ¹æ»ç¼±¿¡´Â ¹ÐºÀ¼Ò¼±¿ø¿¡¼ ³ª¿À´Â ¥ã¼±, Á÷¼±°¡¼Ó±â¿¡¼ ¾ò¾îÁö´Â °í¿¡³ÊÁö X¼±°ú ÀüÀÚ¼±, ÅÚ·¹ÄÚ¹ßÆ®ÀåÄ¡¿¡ ÀÇÇÑ 60CoÀÇ ¥ã¼±°ú, º£Å¸Æ®·Ð¿¡ ÀÇÇÑ ÀüÀÚ¼±, »çÀÌÅ©·ÎÆ®·Ð¿¡¼ ¾ò¾îÁö´Â ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±Ä¡·á |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼±ÀÇ »ì±ÕÈ¿°ú³ª ¼¼Æ÷¸¦ Á×ÀÌ´Â È¿°ú¸¦ Ä¡·á¿¡ ÀÌ¿ëÇÏ´Â ¹æ¹ýÀ¸·Î, Á¼Àº Àǹ̷Π¾ÏÀÇ ¹æ»ç¼±Ä¡·á¸¦ ÀǹÌÇÑ´Ù. ¾Ï¿¡ ´ëÇÑ ¹æ»ç¼±Ä¡·á´Â ¾Ï¼¼Æ÷¸¦ Á×À̴µ¥ È¿°ú°¡ Å« º£Å¸¼±À» ÁÖ·Î »ç¿ëÇÑ´Ù. ÇÏÁö¸¸, ÀÌ·± ¹æ»ç¼±Ä¡·á´Â Á¤»ó¼¼Æ÷¿¡µµ Å« ¿µÇâÀ» ³¢ÃÄ ÀÌ¿¡ µû¸¥ ±â´ÉÀÇ Àå¾Ö¸¦ °¡Á®¿Ã ¼ö ÀÖ´Ù. µû¶ó¼ ¹æ»ç¼±Ä¡·á¿¡ À־ ´ÜÁö ±× ¾Ï¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ë»Ó¸¸ ¾Æ´Ï¶ó, Á¤»ó¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ëµµ °í·ÁÇÏ¿© ½ÃÇàÇÑ´Ù. |
||
| ¿µ¹® | speech therapy | ÇÑ±Û | ¾ð¾îÄ¡·á |
|---|---|---|---|
| ¼³¸í | ¸»À» Á¤È®ÇÏ°Ô ¹ßÀ½ÇÒ ¼ö ¾ø°Å³ª ´õµë´Â ȯÀÚ¿¡°Ô ¹ßÀ½, ´ëÈ µûÀ§ÀÇ ÈÆ·ÃÀ» Àü¹®ÀûÀ¸·Î ÇàÇÏ´Â Ä¡·á¹ý. |
||
| ¿µ¹® | therapy | ÇÑ±Û | ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | º´À» ³´°Ô ÇÏ´Â °Í ¶Ç´Â ±× ¹æ¹ý. |
||
| GT | gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm... |
|---|---|
| RT | radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti... |
| GCS | Glasgow Coma Scale |
| EMV | eye, motor, voice [Glasgow coma scale] |
| GCS | general clinical services; Gianotti-Crosti syndrome; Glasgow Coma Scale; glucocorticosteroid; glutam... |
| insulin coma treatment | Rarely used treatment of major mental illness by means of hypoglycaemic coma induced by insulin. (05 Mar 2000) |
|---|---|
| thyrotoxic coma | Coma preceding death in severe hyperthyroidism, as in thyroid storm or thyrotoxic crisis. (05 Mar 2000) |
| trance coma | The deep sleep following major hypnosis. Synonym: trance coma. (05 Mar 2000) |
| uraemic coma | A metabolic encephalopathy caused by renal failure. (05 Mar 2000) |
| Kussmaul's coma | A severe metabolic derangement that occurs in the absence of insulin. Insulin allows the body to absorb glucose into cells for energy production. In the absence of insulin, the body starts to break down fats for fuel. A metabolic byproduct of fat metabolism is referred to as a ketone. The presence of elevated blood ketones in this setting is known as diabetic ketoacidosis. In extreme, untreated cases, this can lead to coma and death. (27 Sep 1997) |
| acupuncture therapy | Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction. (12 Dec 1998) |
| adjuvant therapy | <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells. (14 May 1997) |
| alternative therapy | A term given to nonconventional therapy usually given by persons who do not have a medical qualification. (16 Dec 1997) |
| analytic therapy | Short term for psychoanalytic therapy. (05 Mar 2000) |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |
| anticoagulant therapy | The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting. (05 Mar 2000) |
| antisense therapy | Use of antisense DNA for the inhibition of translation of a specific gene product for therapeutic purposes. (05 Mar 2000) |
| art therapy | The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioural disorders. (12 Dec 1998) |
| autoserum therapy | Therapy with serum obtained from the patient's own blood. (05 Mar 2000) |
| aversion therapy | <psychology> A form of behaviour therapy that pairs an unpleasant stimulus with undesirable behaviour(s) so that the patient learns to avoid the latter. See: aversive training. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|